EDGAR Filing Documents for 0001144204-17-037890

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-17-037890

Filing Date

2017-07-24

Accepted

2017-07-24 17:17:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	v471229_s3.htm	S-3	236338
2	EXHIBIT 4.2	v471229_ex4-2.htm	EX-4.2	480535
3	EXHIBIT 4.3	v471229_ex4-3.htm	EX-4.3	542856
4	EXHIBIT 5	v471229_ex5.htm	EX-5	28553
5	EXHIBIT 23.1	v471229_ex23-1.htm	EX-23.1	2054
6	EXHIBIT 23.2	v471229_ex23-2.htm	EX-23.2	2487
	Complete submission text file	0001144204-17-037890.txt		1293799

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054

Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160

Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)